Additional file 4 of Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data ...
Additional file 4: Figure S3. Vaccination status of Belgian hospitalized COVID-19 patients registered in the Clinical Hospital Survey (CHS). (Left) Number of Belgian hospitalized COVID-19 patients with a certain vaccination status over time, 7-day rolling average. (Right) Percentage of Belgian hospitalized COVID-19 patients with a certain vaccination status over time, 7-day rolling average. Periods of dominance of SARS-CoV-2 variants (more than 50% presence in baseline surveillance) are indicated as areas on the plot. Not vaccinated = no dose of a vaccine. Partially vaccinated = one dose of th... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Journal contribution |
| Erscheinungsdatum: | 2022 |
| Verlag/Hrsg.: |
figshare
|
| Schlagwörter: | Medicine / Biotechnology / Ecology / FOS: Biological sciences / Immunology / FOS: Clinical medicine / 19999 Mathematical Sciences not elsewhere classified / FOS: Mathematics / Science Policy / 110309 Infectious Diseases / FOS: Health sciences / 60506 Virology |
| Sprache: | unknown |
| Permalink: | https://search.fid-benelux.de/Record/base-28884984 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://dx.doi.org/10.6084/m9.figshare.21546804.v1 |
Additional file 4: Figure S3. Vaccination status of Belgian hospitalized COVID-19 patients registered in the Clinical Hospital Survey (CHS). (Left) Number of Belgian hospitalized COVID-19 patients with a certain vaccination status over time, 7-day rolling average. (Right) Percentage of Belgian hospitalized COVID-19 patients with a certain vaccination status over time, 7-day rolling average. Periods of dominance of SARS-CoV-2 variants (more than 50% presence in baseline surveillance) are indicated as areas on the plot. Not vaccinated = no dose of a vaccine. Partially vaccinated = one dose of the BNT162b2, mRNA-1273 or NVX-CoV2373 vaccine. Fully vaccinated = one dose of the Ad26.COV2.S vaccine, two doses of the BNT162b2, mRNA-1273 or NVX-CoV2373 vaccine, or a mixture of two doses of the latter three vaccines (= primary vaccination schedule). Fully vaccinated + booster = primary vaccination schedule plus an additional dose of the BNT162b2 or mRNA-1273 vaccine. ...